RecruitingPhase 2NCT05500391

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

Randomized Phase II Trial Evaluating Compliance With Monitoring Conducted Either by a Hospital-based Physician in Person or by a Nurse in Remote Monitoring


Sponsor

Centre Oscar Lambret

Enrollment

88 participants

Start Date

Feb 28, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This is a multicenter, interventional, randomized study among adult patients recently diagnosed with a rare tumor (\<12 months). The study will aim to compare compliance with the personalized post-treatment surveillance plan, established for each patient according to national guidelines, when the surveillance is conducted in person by a hospital-based physician (control arm) or remotely by a trained nurse (experimental arm).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This French study is comparing two follow-up methods for cancer patients who need long-term monitoring after treatment: regular in-person visits with a doctor versus remote monitoring done by a nurse. The goal is to see if nurse-led remote monitoring is just as effective and better accepted by patients. **You may be eligible if...** - You are 18 or older and were diagnosed with cancer within the past 12 months - Your cancer is in one of these categories: desmoid tumors, early-stage testicular cancer, low-risk GIST, certain rare gynecological cancers, low-grade glioma, or low-grade neuroendocrine tumors - You have already had surgery or are under active surveillance **You may NOT be eligible if...** - Your cancer is not in one of the qualifying categories - You have not yet received a confirmed tissue diagnosis Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEROncological Follow-up

Post-cancer surveillance (including biological, clinical and imaging exams depending on the condition)


Locations(3)

CHU Amiens

Amiens, France

Centre François Baclesse

Caen, France

Centre Oscar Lambret

Lille, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05500391


Related Trials